Page 4 - Jays Duker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why Shares of EyePoint Pharmaceuticals Were Rising Monday

The company reported positive trial data for its lead therapy to treat two different eye conditions.

Jays dukerEyepoint pharmaceuticalsChief executive officer

EyePoint Pharmaceuticals to Present at the H C Wainwright 3rd Annual Ophthalmology Virtual Conference

EyePoint Pharmaceuticals to Present at the H C Wainwright 3rd Annual Ophthalmology Virtual Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAmy phillipsJays dukerChristina tartagliaEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticalsPanel discussionEyepoint pharmaceuticals toGreen room communicationsEyepoint pharmaceuticals incCompany overviewPoint pharmaceuticalsAnnual ophthalmology virtualChief executiveAnnual ophthalmology virtual conference

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesCzech republicJays dukerJay dukerChristina tartagliaAmy phillipsMarcia sellos mouraAmerican society of retina specialistsProgram leadership onEyepoint pharmaceuticals incEyepoint pharmaceuticalsBetta pharmaceuticalsAlimera sciencesEuropean society of ophthalmology congressExchange commission

EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit

EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJays dukerChristina tartagliastern irdirectEyepoint pharmaceuticals incAlimera sciencesEquinox sciencesExchange commissionEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticalsBetta pharmaceuticalsPoint pharmaceuticalsInnovation summitNancy lurkerExecutive vice chairChief executive officerPrivate securities litigation reform act

EyePoint Pharmaceuticals (EYPT) Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit

EyePoint Pharmaceuticals (EYPT) Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jays dukerEyepoint pharmaceuticalsEyepoint pharmaceuticals incInnovation summitNancy lurkerExecutive vice chairChief executive officer